ArticleJournal of community health2026
Mpox Awareness and Knowledge Among Residents of the Northern Border Region, Saudi Arabia: Implications for Community Preparedness.
Article in Journal of community health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In August 2024, the World Health Organization declared the ongoing mpox upsurge in Africa a Public Health Emergency of International Concern, underscoring mpox as an emerging global threat. In non‑endemic countries such as Saudi Arabia, understanding community awareness is critical for public health preparedness and prevention. This study assessed mpox awareness and knowledge among residents of the Northern Border Region and identified factors associated with better knowledge, to inform targeted community‑based health communication strategies. A community‑based cross‑sectional survey was conducted between 1 March and 20 August 2025 among 1,362 adults. A structured, pre‑validated questionnaire assessed general knowledge, symptom recognition, and preventive measures. Knowledge scores (0-15) were summarized descriptively and categorized as poor, moderate, or good. Ordinal logistic regression and machine‑learning classifiers were used to identify predictors of higher knowledge and to explore the prediction of adequate knowledge from sociodemographic characteristics and prior mpox awareness, supporting risk stratification for community interventions. Among 1,362 participants (78.1% female; 56.8% aged 18-30 years), 48.4% had previously heard of mpox. Overall knowledge was suboptimal (mean 7.64/15; 50.9% correct); 48.3% had poor knowledge, 38.2% moderate, and 13.5% good. Suboptimal knowledge across sociodemographic groups suggests substantial vulnerability to future mpox introductions in this border region. Social media and other internet sources were the main information channels, underscoring their potential as primary platforms for risk communication. In multivariable ordinal regression, prior mpox awareness was the strongest predictor of higher knowledge (adjusted odds = 4.1), alongside higher education and health‑related occupations. Logistic‑regression-based machine‑learning models showed moderate discrimination and acceptable calibration (AUC‑ROC = 0.72; Brier = 0.19), with prior awareness consistently the most important feature. Mpox knowledge in the Northern Border Region is suboptimal and low across sociodemographic groups, particularly among less educated and non‑health‑sector participants. Prior exposure to mpox information is a central, modifiable determinant of adequate knowledge, underscoring the need for targeted, evidence‑based communication strategies, particularly via widely used digital platforms. Tailored community‑level interventions focusing on less educated and non‑health‑sector groups are essential to strengthen mpox preparedness and broader infectious‑disease readiness in this underserved border region.
Indexed as
Identifiers
41942689What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.